Last year, Bionano Genomics Inc generated 13.97M USD for its biggest-performing segment, Consumables. The EMEIA made the largest contribution, accounting for 14.11M USD last year. For the latest quarter, Bionano Genomics Inc reported the revenue of 4.29M USD for the period ending 2026-06-30, which came from the top-performing segment, Consumables. EMEIA contributed the highest revenue, at 4.84M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Consumables

Software

Instruments

Services and other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Consumables

13.97M(49.00%)

12.77M(41.50%)

11.16M(30.89%)

6.73M(24.21%)

5.81M(32.30%)

3.15M(36.99%)

Software

6.41M(22.48%)

6.19M(20.12%)

5.57M(15.43%)

5.13M(18.44%)

--(--)

Instruments

6.36M(22.32%)

8.04M(26.13%)

10.00M(27.69%)

8.57M(30.81%)

5.89M(32.74%)

3.08M(36.28%)

Services and other

1.76M(6.19%)

3.77M(12.24%)

9.39M(26.00%)

7.38M(26.53%)

6.29M(34.96%)

2.27M(26.73%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

EMEIA

Americas

Asia Pacific

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

EMEIA

14.11M(49.49%)

14.23M(46.25%)

12.96M(35.89%)

8.96M(32.23%)

5.60M(31.17%)

3.16M(37.20%)

Americas

12.18M(42.72%)

13.65M(44.35%)

18.02M(49.89%)

13.86M(49.86%)

9.33M(51.88%)

4.49M(52.79%)

Asia Pacific

2.22M(7.79%)

2.89M(9.40%)

5.13M(14.21%)

4.98M(17.91%)

3.05M(16.95%)

851.00K(10.01%)